The increase of GFP-LC3 punctation in glioma cells upon the treatment with both cannabinoids was statistically significant and the induced changes were partially blocked by the autophagy inhibitor 3-methyladenine (3MA) (Figure 6b). The gene discussed is MAP1LC3A; the disease is glioma.